Business | Miloni Bhatt | Tuesday June 4, 2013
The EU claims Ranbaxy and other international pharmaceutical companies blocked the delivery of cheap drugs to the EU market, despite an agreement to deliver. Also, European regulators have estimated that consumers are paying up to 20 per cent more for medicines in some cases.
www.ndtv.com/business